News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
643,253 Results
Type
Article (49278)
Company Profile (124)
Press Release (593843)
Multimedia
Podcasts (200)
Webinars (26)
Section
Business (199639)
Career Advice (2562)
Deals (32138)
Drug Delivery (174)
Drug Development (76960)
Employer Resources (168)
FDA (16724)
Job Trends (13424)
News (307571)
Policy (32145)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
Academia (2427)
Academic (1)
Accelerated approval (60)
ADA (43)
Adcomms (42)
Allergies (190)
Alliances (43489)
ALS (224)
Alzheimer's disease (1932)
Antibody-drug conjugate (ADC) (540)
Approvals (17087)
Artificial intelligence (752)
ASCO (319)
Autoimmune disease (355)
Automation (53)
Bankruptcy (328)
Best Places to Work (9915)
BIO (68)
BIOSECURE Act (23)
Biosimilars (255)
Biotechnology (75)
Bladder cancer (207)
Brain cancer (76)
Breast cancer (779)
Cancer (6212)
Cardiovascular disease (528)
Career advice (2184)
Career pathing (51)
CAR-T (334)
CDC (77)
Celiac Disease (2)
Cell therapy (961)
Cervical cancer (55)
Clinical research (67674)
Collaboration (2122)
Commercialization (1)
Company closure (7)
Compensation (1560)
Complete response letters (110)
COVID-19 (2819)
CRISPR (117)
C-suite (1240)
Cystic fibrosis (157)
Data (8387)
Decentralized trials (3)
Denatured (52)
Depression (200)
Dermatology (99)
Diabetes (651)
Diagnostics (6158)
Digital health (56)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (361)
Drug pricing (244)
Drug shortages (38)
Duchenne muscular dystrophy (322)
Earnings (74671)
Editorial (81)
Employer branding (20)
Employer resources (150)
Events (100036)
Executive appointments (1108)
FDA (20814)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (33)
Funding (1722)
Gene editing (251)
Generative AI (67)
Gene therapy (771)
GLP-1 (1235)
Government (4387)
Grass and pollen (8)
Guidances (412)
Healthcare (15814)
Hematology (180)
HIV (94)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (117)
Immunology and inflammation (354)
Immuno-oncology (109)
Indications (216)
Infectious disease (3187)
Inflammatory bowel disease (224)
Inflation Reduction Act (14)
Influenza (139)
Intellectual property (311)
Interviews (474)
IPO (15271)
IRA (59)
Job creations (3782)
Job search strategy (1779)
JPM (73)
Kidney cancer (23)
Labor market (113)
Layoffs (659)
Leadership (54)
Legal (7774)
Liver cancer (104)
Longevity (29)
Lung cancer (827)
Lymphoma (469)
Machine learning (61)
Management (56)
Manufacturing (1157)
Marketing (5)
MASH (221)
Medical affairs (1)
Medical device (12026)
Medtech (12181)
Mergers & acquisitions (18148)
Metabolic disorders (1751)
mRNA (259)
Multiple sclerosis (193)
NASH (24)
Neurodegenerative disease (492)
Neuropsychiatric disorders (128)
Neuroscience (3616)
Neurotech (2)
NextGen: Class of 2026 (5294)
Non-profit (3367)
Now hiring (50)
Obesity (857)
Opinion (344)
Ovarian cancer (224)
Pain (268)
Pancreatic cancer (352)
Parkinson's disease (406)
Partnered (32)
Patents (645)
Patient recruitment (760)
Peanut (66)
People (53734)
Pharmaceutical (45)
Pharmacy benefit managers (36)
Phase 1 (20369)
Phase 2 (29474)
Phase 3 (23311)
Pipeline (9759)
Policy (398)
Postmarket research (2560)
Preclinical (8439)
Press Release (48)
Prostate cancer (344)
Psychedelics (72)
Radiopharmaceuticals (335)
Rare diseases (1271)
Real estate (5273)
Recruiting (70)
Regulatory (26121)
Reports (49)
Research institute (2283)
Resumes & cover letters (421)
Rett syndrome (46)
RNA editing (28)
RSV (88)
Schizophrenia (194)
Series A (304)
Series B (224)
Service/supplier (6)
Sickle cell disease (125)
Special edition (30)
Spinal muscular atrophy (174)
Sponsored (52)
Startups (3324)
State (2)
Stomach cancer (21)
Supply chain (141)
Tariffs (104)
The Weekly (145)
Vaccines (1255)
Venture capital (137)
Weight loss (594)
Women's health (125)
Worklife (25)
Date
Last 7 days (389)
Last 30 days (1761)
Last 365 days (29718)
2026 (16366)
2025 (29683)
2024 (33203)
2023 (37219)
2022 (47704)
2021 (51381)
2020 (48647)
2019 (39197)
2018 (29900)
2017 (30544)
2016 (29174)
2015 (32676)
2014 (26562)
2013 (22192)
2012 (23752)
2011 (24429)
2010 (22346)
Location
Africa (782)
Alabama (79)
Alaska (7)
Arizona (307)
Arkansas (13)
Asia (39453)
Australia (6462)
California (13520)
Canada (3452)
China (1462)
Colorado (566)
Connecticut (619)
Delaware (423)
Europe (90923)
Florida (2078)
Georgia (412)
Hawaii (4)
Idaho (44)
Illinois (1058)
India (100)
Indiana (561)
Iowa (23)
Japan (600)
Kansas (122)
Kentucky (49)
Louisiana (41)
Maine (80)
Maryland (1619)
Massachusetts (9772)
Michigan (313)
Minnesota (693)
Mississippi (5)
Missouri (141)
Montana (18)
Nebraska (27)
Nevada (139)
New Hampshire (70)
New Jersey (3605)
New Mexico (19)
New York (3509)
North Carolina (1750)
North Dakota (8)
Northern California (6895)
Ohio (376)
Oklahoma (20)
Oregon (35)
Pennsylvania (2571)
Puerto Rico (26)
Rhode Island (35)
South America (1149)
South Carolina (86)
South Dakota (2)
Southern California (5361)
Tennessee (211)
Texas (2093)
United States (47264)
Utah (336)
Vermont (1)
Virginia (334)
Washington D.C. (78)
Washington State (1054)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
643,253 Results for "rhizen pharmaceuticals s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuropsychiatric disorders
Otsuka’s drug eases symptom burden, anxiety in ADHD as FDA verdict nears
The positive ADHD data for Otsuka Pharmaceutical’s centanafadine is good news in what has of late been a mixed bag for the neuropsychiatric space.
June 26, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
GSK and Hansoh Pharmaceutical’s antibody-drug conjugate success validates their partnership, one of the many deals in which Big Pharma has tapped a China company for promising cancer candidates.
July 10, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Marius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health
June 22, 2026
·
4 min read
Press Releases
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
July 7, 2026
·
7 min read
Press Releases
Quoin Pharmaceuticals Receives U.S. Notice of Allowance for Patent Covering Combination Treatment for Netherton Syndrome
June 30, 2026
·
7 min read
Press Releases
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4
July 7, 2026
·
1 min read
Schizophrenia
Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia study
The patient death occurred outside the U.S. and was deemed unrelated to Newron Pharmaceuticals’ investigational schizophrenia drug.
April 30, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate
June 10, 2026
·
2 min read
Business
Sanofi’s R&D head exits, with AI biotech Xaira’s exec stepping in
About two months into CEO Belén Garijo’s new tenure, Sanofi’s R&D chief has departed, with Xaira’s chief medical officer set to take charge of the pharma’s pipeline.
June 22, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC
July 7, 2026
·
10 min read
1 of 64,326
Next
